Citadel Advisors - ALTERITY THERAPEUTICS LTD ownership

ALTERITY THERAPEUTICS LTD's ticker is ATHE and the CUSIP is 02155X106. A total of 14 filers reported holding ALTERITY THERAPEUTICS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ALTERITY THERAPEUTICS LTD
ValueSharesWeighting
Q1 2022$19,000
+26.7%
23,576
+100.5%
0.00%
Q3 2021$15,000
-69.4%
11,761
-69.0%
0.00%
Q2 2021$49,000
-47.9%
37,980
-41.6%
0.00%
Q1 2021$94,00065,0110.00%
Other shareholders
ALTERITY THERAPEUTICS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 19,590$16,0000.00%
TCWP LLC 7,750$6,0000.00%
UBS Group AG 10,487$9,0000.00%
Sugarloaf Wealth Management, LLC 333$00.00%
OSAIC HOLDINGS, INC. 375$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 12,128$9,0000.00%
MORGAN STANLEY 579,964$481,0000.00%
ENVESTNET ASSET MANAGEMENT INC 82,386$67,0000.00%
Citadel Advisors 23,576$19,0000.00%
View complete list of ALTERITY THERAPEUTICS LTD shareholders